Predict your next investment

HEALTHCARE | Drug Development

See what CB Insights has to offer

Founded Year



Angel | IPO

Total Raised


About Cortendo Invest

Developer of pharmaceutical research and development for the treatment of stress related disorders. The company develops solutions based on the discovery that normalizing levels of the stress hormone cortisol provides a new therapeutic approach to the treatment of stress-related disorders. Its research interests revolve around disorders such as metabolic syndrome, obesity, insulin resistance, dyslipidaemia, hypertension, and type II diabetes.

Cortendo Invest Headquarter Location

Box 47

Partille, 433 21,


46 3 126 30 10

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Cortendo Invest

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Cortendo Invest is included in 2 Expert Collections, including Diabetes.



1,734 items



5,731 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.